Successful Use of Quinine in the Treatment of Electrical Storm in a Child with Brugada Syndrome

Gellens, 1992, Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel, Proc Nat Acad Sci USA, 89, 554, 10.1073/pnas.89.2.554

Chen, 1998, Genetic basis and molecular mechanism for idiopathic ventricular fibrillation, Nature, 392, 293, 10.1038/32675

Brugada, 1998, Right bundle-branch block and ST-segment elevation in leads V1 through V3: A marker for sudden death in patients without demonstrable structural heart disease, Circulation, 97, 457, 10.1161/01.CIR.97.5.457

Alings, 1999, “Brugada” syndrome: Clinical data and suggested pathophysiological mechanism, Circulation, 99, 666, 10.1161/01.CIR.99.5.666

Shu, 2005, ST-segment elevation in the early repolarization syndrome, idiopathic ventricular fibrillation, and the Brugada syndrome: Cellular and clinical linkage, J Electrocardiol, 38, 26, 10.1016/j.jelectrocard.2005.06.006

Gussak, 2000, Early repolarization syndrome: Clinical characteristics and possible cellular and ionic mechanisms, J Electrocardiol, 33, 299, 10.1054/jelc.2000.18106

Haïssaguerre, 2008, Sudden cardiac arrest associated with early repolarization, N Engl J Med, 358, 2016, 10.1056/NEJMoa071968

Haïssaguerre, 2009, Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization, J Am Coll Cardiol, 53, 612, 10.1016/j.jacc.2008.10.044

Matsuo, 1998, Dynamic changes of 12-lead electrocardiograms in a patient with Brugada syndrome, J Cardiovasc Electrophysiol, 9, 508, 10.1111/j.1540-8167.1998.tb01843.x

Yan, 1999, Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST segment elevation, Circulation, 100, 1660, 10.1161/01.CIR.100.15.1660

Belhassen, 2004, Efficacy of quinidine in high-risk patients with Brugada syndrome, Circulation, 110, 1731, 10.1161/01.CIR.0000143159.30585.90

Alings, 2001, Quinidine induced electrocardiographic normalization in two patients with Brugada syndrome, Pacing Clin Electrophysiol, 24, 1420, 10.1046/j.1460-9592.2001.01420.x

Antzelevitch, 2001, The Brugada syndrome: ionic basis and arrhythmia mechanisms, J Cardiovasc Electrophysiol, 12, 268, 10.1046/j.1540-8167.2001.00268.x

Shimizu, 2005, Mechanisms of disease: Current understanding and future challenges in Brugada syndrome, Nat Clin Pract Cardiovasc Med, 2, 408, 10.1038/ncpcardio0268

Ohgo, 2007, Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation, Heart Rhythm, 4, 695, 10.1016/j.hrthm.2007.02.014

Tsuchiya, 2002, Prevention of ventricular fibrillation by cilostazol, an oral phosphodiesterase inhibitor, in a patient with Brugada syndrome, J Cardiovasc Electrophysiol, 13, 698, 10.1046/j.1540-8167.2002.00698.x

Mirro, 1981, Electrophysiologic effects of the optical isomers of disopyramide and quinidine in the dog: Dependence of stereochemistry, Circ Res, 48, 867, 10.1161/01.RES.48.6.867

Jurkiewicz, 1985, Antiarrhythmic action of quinidine: Relative importance of QT prolongation versus use dependence, Circulation, 71, II

Hill, 1988, Determinants of stereospecific binding of type I drugs to cardiac sodium channels, Mol Pharmacol, 34, 659

Bird, 1985, Use-dependent block of Vmax by quinidine in dog Purkinje fibres is not stereospecific, Circulation, 72, III

Sheldon, 1995, Antiarrhythmic activity of quinine in humans, Circulation, 92, 2944, 10.1161/01.CIR.92.10.2944

Leitch, 1991, Reduction in defibrillator shocks with an implantable device combining antitachycardia pacing and shock therapy, J Am Coll Cardiol, 18, 145, 10.1016/S0735-1097(10)80232-3